Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2022-01-19

AUTHORS

Marc Evans, Angharad R. Morgan, Stephen C. Bain, Sarah Davies, Debbie Hicks, Pam Brown, Zaheer Yousef, Umesh Dashora, Adie Viljoen, Hannah Beba, W. David Strain

ABSTRACT

While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the only route for semaglutide administration was via subcutaneous injection. However, an oral formulation of semaglutide was recently licensed, with the potential to address therapy inertia and increase patient adherence to treatment, which is essential in controlling blood glucose and reducing complications. The availability of oral semaglutide provides a new option for both clinicians and patients who are reluctant to use an injectable agent. This has been of particular importance in addressing the challenge of virtual diabetes care during the COVID-19 pandemic, circumventing the logistical problems that are often associated with subcutaneous medication administration. However, there remains limited awareness of the clinical and economic value of oral semaglutide in routine clinical practice. In this article, we present our consensus opinion on the role of oral semaglutide in routine clinical practice and discuss its value in reducing the burden of delivering diabetes care in the post-COVID-19 pandemic period of chronic disease management. More... »

PAGES

225-240

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z

DOI

http://dx.doi.org/10.1007/s13300-021-01201-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1144777213

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35044569


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/grid.273109.e", 
          "name": [
            "Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Evans", 
        "givenName": "Marc", 
        "id": "sg:person.01167546340.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Health Economics and Outcomes Research Ltd., Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/grid.512413.0", 
          "name": [
            "Health Economics and Outcomes Research Ltd., Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morgan", 
        "givenName": "Angharad R.", 
        "id": "sg:person.015620765533.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015620765533.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Research Unit, Swansea University Medical School, Swansea, UK", 
          "id": "http://www.grid.ac/institutes/grid.4827.9", 
          "name": [
            "Diabetes Research Unit, Swansea University Medical School, Swansea, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bain", 
        "givenName": "Stephen C.", 
        "id": "sg:person.015324426577.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015324426577.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Woodlands Medical Centre, Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Woodlands Medical Centre, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davies", 
        "givenName": "Sarah", 
        "id": "sg:person.013762121575.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013762121575.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medicus Health Partners, Enfield, London, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medicus Health Partners, Enfield, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hicks", 
        "givenName": "Debbie", 
        "id": "sg:person.0604761477.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604761477.76"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "SA1 Medical Centre, Swansea, UK", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "SA1 Medical Centre, Swansea, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brown", 
        "givenName": "Pam", 
        "id": "sg:person.015765201507.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015765201507.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wales Heart Research Institute, Cardiff University, Cardiff, UK", 
          "id": "http://www.grid.ac/institutes/grid.5600.3", 
          "name": [
            "Wales Heart Research Institute, Cardiff University, Cardiff, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yousef", 
        "givenName": "Zaheer", 
        "id": "sg:person.01171526317.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171526317.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "East Sussex Healthcare NHS Trust, Seaford, UK", 
          "id": "http://www.grid.ac/institutes/grid.439656.b", 
          "name": [
            "East Sussex Healthcare NHS Trust, Seaford, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dashora", 
        "givenName": "Umesh", 
        "id": "sg:person.01050674114.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050674114.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "East and North Hertfordshire NHS Trust, Stevenage, UK", 
          "id": "http://www.grid.ac/institutes/grid.439624.e", 
          "name": [
            "East and North Hertfordshire NHS Trust, Stevenage, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Viljoen", 
        "givenName": "Adie", 
        "id": "sg:person.01312211026.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312211026.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "County Durham and Darlington NHS Foundation Trust, Durham, UK", 
          "id": "http://www.grid.ac/institutes/grid.412907.9", 
          "name": [
            "County Durham and Darlington NHS Foundation Trust, Durham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beba", 
        "givenName": "Hannah", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK", 
          "id": "http://www.grid.ac/institutes/grid.416118.b", 
          "name": [
            "Diabetes and Vascular Research Centre, University of Exeter Medical School, Exeter, UK", 
            "The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strain", 
        "givenName": "W. David", 
        "id": "sg:person.0770350302.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770350302.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s13300-021-01034-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1136423665", 
          "https://doi.org/10.1007/s13300-021-01034-w"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-020-00883-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1129560870", 
          "https://doi.org/10.1007/s13300-020-00883-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12902-021-00798-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1139157917", 
          "https://doi.org/10.1186/s12902-021-00798-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40262-018-0649-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1103179714", 
          "https://doi.org/10.1007/s40262-018-0649-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12933-015-0260-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053028267", 
          "https://doi.org/10.1186/s12933-015-0260-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-019-00736-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1123313018", 
          "https://doi.org/10.1007/s13300-019-00736-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s13300-020-00989-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1134461617", 
          "https://doi.org/10.1007/s13300-020-00989-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrdp.2015.19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006052568", 
          "https://doi.org/10.1038/nrdp.2015.19"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-01-19", 
    "datePublishedReg": "2022-01-19", 
    "description": "While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the only route for semaglutide administration was via subcutaneous injection. However, an oral formulation of semaglutide was recently licensed, with the potential to address therapy inertia and increase patient adherence to treatment, which is essential in controlling blood glucose and reducing complications. The availability of oral semaglutide provides a new option for both clinicians and patients who are reluctant to use an injectable agent. This has been of particular importance in addressing the challenge of virtual diabetes care during the COVID-19 pandemic, circumventing the logistical problems that are often associated with subcutaneous medication administration. However, there remains limited awareness of the clinical and economic value of oral semaglutide in routine clinical practice. In this article, we present our consensus opinion on the role of oral semaglutide in routine clinical practice and discuss its value in reducing the burden of delivering diabetes care in the post-COVID-19 pandemic period of chronic disease management.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13300-021-01201-z", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1044057", 
        "issn": [
          "1869-6953", 
          "1869-6961"
        ], 
        "name": "Diabetes Therapy", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "routine clinical practice", 
      "oral semaglutide", 
      "diabetes care", 
      "clinical practice", 
      "glucagon-like peptide-1 receptor agonists", 
      "peptide-1 receptor agonists", 
      "type 2 diabetes", 
      "chronic disease management", 
      "patient adherence", 
      "receptor agonist", 
      "blood glucose", 
      "subcutaneous injection", 
      "medication administration", 
      "injectable agents", 
      "oral formulation", 
      "effective drugs", 
      "semaglutide", 
      "consensus opinion", 
      "disease management", 
      "care", 
      "COVID-19 pandemic", 
      "consensus viewpoint", 
      "administration", 
      "new options", 
      "limited awareness", 
      "pandemic period", 
      "complications", 
      "diabetes", 
      "patients", 
      "agonists", 
      "clinicians", 
      "drugs", 
      "adherence", 
      "logistical problems", 
      "treatment", 
      "injection", 
      "burden", 
      "glucose", 
      "only route", 
      "practice", 
      "pandemic", 
      "options", 
      "agents", 
      "particular importance", 
      "management", 
      "period", 
      "role", 
      "awareness", 
      "people", 
      "challenges", 
      "values", 
      "opinion", 
      "potential", 
      "importance", 
      "positioning", 
      "route", 
      "availability", 
      "article", 
      "formulation", 
      "problem", 
      "viewpoint", 
      "economic value", 
      "inertia"
    ], 
    "name": "Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice", 
    "pagination": "225-240", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1144777213"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13300-021-01201-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35044569"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13300-021-01201-z", 
      "https://app.dimensions.ai/details/publication/pub.1144777213"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_936.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13300-021-01201-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13300-021-01201-z'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      95 URIs      79 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13300-021-01201-z schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author Nc06d7fc74d1c475ab30f1ca776219773
4 schema:citation sg:pub.10.1007/s13300-019-00736-6
5 sg:pub.10.1007/s13300-020-00883-1
6 sg:pub.10.1007/s13300-020-00989-6
7 sg:pub.10.1007/s13300-021-01034-w
8 sg:pub.10.1007/s40262-018-0649-2
9 sg:pub.10.1038/nrdp.2015.19
10 sg:pub.10.1186/s12902-021-00798-3
11 sg:pub.10.1186/s12933-015-0260-x
12 schema:datePublished 2022-01-19
13 schema:datePublishedReg 2022-01-19
14 schema:description While glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are among the most effective drugs for treating people with type 2 diabetes (T2D), they are clinically under-utilised. Until recently, the only route for semaglutide administration was via subcutaneous injection. However, an oral formulation of semaglutide was recently licensed, with the potential to address therapy inertia and increase patient adherence to treatment, which is essential in controlling blood glucose and reducing complications. The availability of oral semaglutide provides a new option for both clinicians and patients who are reluctant to use an injectable agent. This has been of particular importance in addressing the challenge of virtual diabetes care during the COVID-19 pandemic, circumventing the logistical problems that are often associated with subcutaneous medication administration. However, there remains limited awareness of the clinical and economic value of oral semaglutide in routine clinical practice. In this article, we present our consensus opinion on the role of oral semaglutide in routine clinical practice and discuss its value in reducing the burden of delivering diabetes care in the post-COVID-19 pandemic period of chronic disease management.
15 schema:genre article
16 schema:isAccessibleForFree true
17 schema:isPartOf N3732e9501c594de8b73405c6af476b19
18 N9c019d12544a421f8108e1513458d203
19 sg:journal.1044057
20 schema:keywords COVID-19 pandemic
21 adherence
22 administration
23 agents
24 agonists
25 article
26 availability
27 awareness
28 blood glucose
29 burden
30 care
31 challenges
32 chronic disease management
33 clinical practice
34 clinicians
35 complications
36 consensus opinion
37 consensus viewpoint
38 diabetes
39 diabetes care
40 disease management
41 drugs
42 economic value
43 effective drugs
44 formulation
45 glucagon-like peptide-1 receptor agonists
46 glucose
47 importance
48 inertia
49 injectable agents
50 injection
51 limited awareness
52 logistical problems
53 management
54 medication administration
55 new options
56 only route
57 opinion
58 options
59 oral formulation
60 oral semaglutide
61 pandemic
62 pandemic period
63 particular importance
64 patient adherence
65 patients
66 people
67 peptide-1 receptor agonists
68 period
69 positioning
70 potential
71 practice
72 problem
73 receptor agonist
74 role
75 route
76 routine clinical practice
77 semaglutide
78 subcutaneous injection
79 treatment
80 type 2 diabetes
81 values
82 viewpoint
83 schema:name Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical Practice
84 schema:pagination 225-240
85 schema:productId N3f7abc2627244c70b994a7b625b36b6e
86 Nb0a5d87fc72645ee92a32e4419900963
87 Nbd1ee935bb2e463c96e9852086412ef4
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1144777213
89 https://doi.org/10.1007/s13300-021-01201-z
90 schema:sdDatePublished 2022-10-01T06:50
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N3be54f8be48942328f2433affdd520f6
93 schema:url https://doi.org/10.1007/s13300-021-01201-z
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N053785ea742040c78649ec22e8806099 rdf:first N790d80665df5443695650b3b68ce9f9a
98 rdf:rest N366580fc2d4045cabae8d5dca013d7d9
99 N366580fc2d4045cabae8d5dca013d7d9 rdf:first sg:person.0770350302.52
100 rdf:rest rdf:nil
101 N3732e9501c594de8b73405c6af476b19 schema:issueNumber 2
102 rdf:type schema:PublicationIssue
103 N3be54f8be48942328f2433affdd520f6 schema:name Springer Nature - SN SciGraph project
104 rdf:type schema:Organization
105 N3f7abc2627244c70b994a7b625b36b6e schema:name pubmed_id
106 schema:value 35044569
107 rdf:type schema:PropertyValue
108 N3ffcdf8ed05a43779b8b78690e260a58 rdf:first sg:person.015324426577.19
109 rdf:rest N52517af5f1d44c02aae534f5ade3facf
110 N52517af5f1d44c02aae534f5ade3facf rdf:first sg:person.013762121575.87
111 rdf:rest Ne95d230702f5452b9d7b3f26f371d450
112 N57129f25f9ce43b6a0314107fd163ff4 rdf:first sg:person.01312211026.59
113 rdf:rest N053785ea742040c78649ec22e8806099
114 N638418d0fef143e9ad6fee391562b0ef rdf:first sg:person.015620765533.24
115 rdf:rest N3ffcdf8ed05a43779b8b78690e260a58
116 N790d80665df5443695650b3b68ce9f9a schema:affiliation grid-institutes:grid.412907.9
117 schema:familyName Beba
118 schema:givenName Hannah
119 rdf:type schema:Person
120 N84132070b916449f9e5ac5952306018d rdf:first sg:person.01171526317.16
121 rdf:rest Nbbfac2d540344340a913a9bbe8b53d11
122 N9c019d12544a421f8108e1513458d203 schema:volumeNumber 13
123 rdf:type schema:PublicationVolume
124 Nb0a5d87fc72645ee92a32e4419900963 schema:name doi
125 schema:value 10.1007/s13300-021-01201-z
126 rdf:type schema:PropertyValue
127 Nbbfac2d540344340a913a9bbe8b53d11 rdf:first sg:person.01050674114.03
128 rdf:rest N57129f25f9ce43b6a0314107fd163ff4
129 Nbd1ee935bb2e463c96e9852086412ef4 schema:name dimensions_id
130 schema:value pub.1144777213
131 rdf:type schema:PropertyValue
132 Nc06d7fc74d1c475ab30f1ca776219773 rdf:first sg:person.01167546340.80
133 rdf:rest N638418d0fef143e9ad6fee391562b0ef
134 Ne95d230702f5452b9d7b3f26f371d450 rdf:first sg:person.0604761477.76
135 rdf:rest Nf35d9bd8f28d40509e114fa8eb243c39
136 Nf35d9bd8f28d40509e114fa8eb243c39 rdf:first sg:person.015765201507.16
137 rdf:rest N84132070b916449f9e5ac5952306018d
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
142 schema:name Clinical Sciences
143 rdf:type schema:DefinedTerm
144 sg:journal.1044057 schema:issn 1869-6953
145 1869-6961
146 schema:name Diabetes Therapy
147 schema:publisher Springer Nature
148 rdf:type schema:Periodical
149 sg:person.01050674114.03 schema:affiliation grid-institutes:grid.439656.b
150 schema:familyName Dashora
151 schema:givenName Umesh
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01050674114.03
153 rdf:type schema:Person
154 sg:person.01167546340.80 schema:affiliation grid-institutes:grid.273109.e
155 schema:familyName Evans
156 schema:givenName Marc
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80
158 rdf:type schema:Person
159 sg:person.01171526317.16 schema:affiliation grid-institutes:grid.5600.3
160 schema:familyName Yousef
161 schema:givenName Zaheer
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171526317.16
163 rdf:type schema:Person
164 sg:person.01312211026.59 schema:affiliation grid-institutes:grid.439624.e
165 schema:familyName Viljoen
166 schema:givenName Adie
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01312211026.59
168 rdf:type schema:Person
169 sg:person.013762121575.87 schema:affiliation grid-institutes:None
170 schema:familyName Davies
171 schema:givenName Sarah
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013762121575.87
173 rdf:type schema:Person
174 sg:person.015324426577.19 schema:affiliation grid-institutes:grid.4827.9
175 schema:familyName Bain
176 schema:givenName Stephen C.
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015324426577.19
178 rdf:type schema:Person
179 sg:person.015620765533.24 schema:affiliation grid-institutes:grid.512413.0
180 schema:familyName Morgan
181 schema:givenName Angharad R.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015620765533.24
183 rdf:type schema:Person
184 sg:person.015765201507.16 schema:affiliation grid-institutes:None
185 schema:familyName Brown
186 schema:givenName Pam
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015765201507.16
188 rdf:type schema:Person
189 sg:person.0604761477.76 schema:affiliation grid-institutes:None
190 schema:familyName Hicks
191 schema:givenName Debbie
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604761477.76
193 rdf:type schema:Person
194 sg:person.0770350302.52 schema:affiliation grid-institutes:grid.416118.b
195 schema:familyName Strain
196 schema:givenName W. David
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770350302.52
198 rdf:type schema:Person
199 sg:pub.10.1007/s13300-019-00736-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1123313018
200 https://doi.org/10.1007/s13300-019-00736-6
201 rdf:type schema:CreativeWork
202 sg:pub.10.1007/s13300-020-00883-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1129560870
203 https://doi.org/10.1007/s13300-020-00883-1
204 rdf:type schema:CreativeWork
205 sg:pub.10.1007/s13300-020-00989-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1134461617
206 https://doi.org/10.1007/s13300-020-00989-6
207 rdf:type schema:CreativeWork
208 sg:pub.10.1007/s13300-021-01034-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1136423665
209 https://doi.org/10.1007/s13300-021-01034-w
210 rdf:type schema:CreativeWork
211 sg:pub.10.1007/s40262-018-0649-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103179714
212 https://doi.org/10.1007/s40262-018-0649-2
213 rdf:type schema:CreativeWork
214 sg:pub.10.1038/nrdp.2015.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006052568
215 https://doi.org/10.1038/nrdp.2015.19
216 rdf:type schema:CreativeWork
217 sg:pub.10.1186/s12902-021-00798-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1139157917
218 https://doi.org/10.1186/s12902-021-00798-3
219 rdf:type schema:CreativeWork
220 sg:pub.10.1186/s12933-015-0260-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053028267
221 https://doi.org/10.1186/s12933-015-0260-x
222 rdf:type schema:CreativeWork
223 grid-institutes:None schema:alternateName Medicus Health Partners, Enfield, London, UK
224 SA1 Medical Centre, Swansea, UK
225 Woodlands Medical Centre, Cardiff, UK
226 schema:name Medicus Health Partners, Enfield, London, UK
227 SA1 Medical Centre, Swansea, UK
228 Woodlands Medical Centre, Cardiff, UK
229 rdf:type schema:Organization
230 grid-institutes:grid.273109.e schema:alternateName Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK
231 schema:name Diabetes Resource Centre, University Hospital Llandough, Penlan Road, Llandough, CF64 2XX, Cardiff, UK
232 rdf:type schema:Organization
233 grid-institutes:grid.412907.9 schema:alternateName County Durham and Darlington NHS Foundation Trust, Durham, UK
234 schema:name County Durham and Darlington NHS Foundation Trust, Durham, UK
235 rdf:type schema:Organization
236 grid-institutes:grid.416118.b schema:alternateName The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK
237 schema:name Diabetes and Vascular Research Centre, University of Exeter Medical School, Exeter, UK
238 The Academic Department of Healthcare for Older Adults, Royal Devon and Exeter Hospital, Exeter, UK
239 rdf:type schema:Organization
240 grid-institutes:grid.439624.e schema:alternateName East and North Hertfordshire NHS Trust, Stevenage, UK
241 schema:name East and North Hertfordshire NHS Trust, Stevenage, UK
242 rdf:type schema:Organization
243 grid-institutes:grid.439656.b schema:alternateName East Sussex Healthcare NHS Trust, Seaford, UK
244 schema:name East Sussex Healthcare NHS Trust, Seaford, UK
245 rdf:type schema:Organization
246 grid-institutes:grid.4827.9 schema:alternateName Diabetes Research Unit, Swansea University Medical School, Swansea, UK
247 schema:name Diabetes Research Unit, Swansea University Medical School, Swansea, UK
248 rdf:type schema:Organization
249 grid-institutes:grid.512413.0 schema:alternateName Health Economics and Outcomes Research Ltd., Cardiff, UK
250 schema:name Health Economics and Outcomes Research Ltd., Cardiff, UK
251 rdf:type schema:Organization
252 grid-institutes:grid.5600.3 schema:alternateName Wales Heart Research Institute, Cardiff University, Cardiff, UK
253 schema:name Wales Heart Research Institute, Cardiff University, Cardiff, UK
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...